Table 2.

Univariate analysis of predictive values for resumption of menstruation.

Characteristics	Subgroups	Event	Total	Menstruation return mean ± s.d. (months)	P Value
Age	<40	16	22	13.2 ± 3.2
	≥40	36	60	23.4 ± 2.9	0.009
BMI	<27	44	69	22.0 ± 2.6
	≥27	8	13	12.6 ± 3.7	0.104
Chemotherapy regimen	Anthracycline + cyclophosphamide	30	42	16.6 ± 2.9	–
	Anthracycline + cyclophosphamide followed by taxane	14	27	21.7 ± 3.8	0.092
	Anthracycline + taxane	8	13	31.1 ± 6.7	0.205
Oestradiol	Ovarian failure (<37 pg/mL)	46	74	22.1 ± 2.5
	Functional ovarian reserve (≥37 pg/mL)	6	8	6.9 ± 1.7	0.003
Anti-Müllerian hormone	Ovarian failure (<800 pg/mL)	4	9	34.1 ± 7.7
	Functional ovarian reserve (≥800 pg/mL)	48	73	18.5 ± 2.3	0.026
Inhibin B	Ovarian failure (<30 pg/mL)	19	32	14.4 ± 2.4
	Functional ovarian reserve (≥30 pg/mL)	33	50	23.4 ± 3.1	0.263